29 research outputs found
Influence of affective image content on subjective quality assessment
Image quality assessment (IQA) enables distortions introduced into an image (e.g., through lossy compression or broadcast) to be measured and evaluated for severity. It is unclear to what degree affective image content may influence this process. In this study, participants (n=25) were found to be unable to disentangle affective image content from objective image quality in a standard IQA procedure (single stimulus numerical categorical scale). We propose that this issue is worthy of consideration, particularly in single stimulus IQA techniques, in which a small number of handpicked images, not necessarily representative of the gamut of affect seen in true broadcasting, and unrated for affective content, serve as stimuli
EMDR Effects on Pursuit Eye Movements
This study aimed to objectivize the quality of smooth pursuit eye movements in a standard laboratory task before and after an Eye Movement Desensitization and Reprocessing (EMDR) session run on seven healthy volunteers. EMDR was applied on autobiographic worries causing moderate distress. The EMDR session was complete in 5 out of the 7 cases; distress measured by SUDS (Subjective Units of Discomfort Scale) decreased to a near zero value. Smooth pursuit eye movements were recorded by an Eyelink II video system before and after EMDR. For the five complete sessions, pursuit eye movement improved after their EMDR session. Notably, the number of saccade intrusionsâcatch-up saccades (CUS)âdecreased and, reciprocally, there was an increase in the smooth components of the pursuit. Such an increase in the smoothness of the pursuit presumably reflects an improvement in the use of visual attention needed to follow the target accurately. Perhaps EMDR reduces distress thereby activating a cholinergic effect known to improve ocular pursuit
An integrative review on facilitators and barriers in delivering and managing injectable therapies in chronic conditions: A part of the ACNAP project âinjectable medicines among patients with cardiovascular conditionsâ
Introduction: Although preventive health and therapeutics have benefited from advances in drug development and device innovation, translating these evidence-based treatments into real-world practice remains challenging.
Aim: The current integrative review aims to identify facilitators and barriers and perceptions in delivering and managing injectable therapies from patient perspectives.
Methods: An integrative review was conducted in the databases of PubMed, CINAHL, PsycINFO and Cochrane. Keywords were used âInjectable therapyâ, âIV therapyâ, âSC therapyâ, âlong term injectable therapiesâ, âself-administered injectable therapyâ, âpatientsâ, âcaregiversâ, âfamilyâ, âcarersâ, âfacilitatorsâ, âbarriersâ, âperspectivesâ, âneedsâ, âexpectationsâ, âchronic diseaseâ, âcardiovascular diseaseâ linked with the words âORâ and âANDâ. The search was limited from January 2000 to July 2019. Inclusion and exclusion criteria were used.
Results: Twenty studies were identified from the literature search. Studies followed qualitative, quantitative methodology and mixed methods. Facilitators included: health improvement, prevention of disease complications, taking control of their disease, effectiveness of the medication and convenience in management. Barriers included: fear of needles, insulin will cause harm, poor perception of the benefits of injectable therapies on their quality of life, inconvenience in self-management, social stigma, impact on daily living, financial barriers, lack of education. Perceptions included: âtreatment of last resortâ, âlife becomes less flexibleâ, âinjectables were punishment/restrictionâ, âpersonal failure of self-managementâ.
Conclusion: Evidence shows how to create effective communication and shared decision-making relationships to provide best possible care to patients who need injectable therapy and support for self-management. Future research might help guide response to the fears and barriers of the patients using patientsâ perspectives
An integrative review on facilitators and barriers in delivering and managing injectable therapies in chronic conditions: A part of the ACNAP project âinjectable medicines among patients with cardiovascular conditionsâ
Introduction:
Although preventive health and therapeutics have benefited from advances in drug development and device innovation, translating these evidence-based treatments into real-world practice remains challenging.
Aim:
The current integrative review aims to identify facilitators and barriers and perceptions in delivering and managing injectable therapies from patient perspectives.
Methods:
An integrative review was conducted in the databases of PubMed, CINAHL, PsycINFO and Cochrane. Keywords were used âInjectable therapyâ, âIV therapyâ, âSC therapyâ, âlong term injectable therapiesâ, âself-administered injectable therapyâ, âpatientsâ, âcaregiversâ, âfamilyâ, âcarersâ, âfacilitatorsâ, âbarriersâ, âperspectivesâ, âneedsâ, âexpectationsâ, âchronic diseaseâ, âcardiovascular diseaseâ linked with the words âORâ and âANDâ. The search was limited from January 2000 to July 2019. Inclusion and exclusion criteria were used.
Results:
Twenty studies were identified from the literature search. Studies followed qualitative, quantitative methodology and mixed methods. Facilitators included: health improvement, prevention of disease complications, taking control of their disease, effectiveness of the medication and convenience in management. Barriers included: fear of needles, insulin will cause harm, poor perception of the benefits of injectable therapies on their quality of life, inconvenience in self-management, social stigma, impact on daily living, financial barriers, lack of education. Perceptions included: âtreatment of last resortâ, âlife becomes less flexibleâ, âinjectables were punishment/restrictionâ, âpersonal failure of self-managementâ.
Conclusion:
Evidence shows how to create effective communication and shared decision-making relationships to provide best possible care to patients who need injectable therapy and support for self-management. Future research might help guide response to the fears and barriers of the patients using patientsâ perspectives